Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats
The DOI matches its Crossref record.
Abstract
A nonselective inhibitor of cyclooxygenase (COX; high-dose aspirin) and a relatively selective inhibitor of inducible nitric oxide synthase (iNOS; aminoguanidine) have been found to inhibit development of diabetic retinopathy in animals, raising a possibility that NOS and COX play important roles in the development of retinopathy. In this study, the effects of hyperglycemia on retinal nitric oxide (NO) production and the COX-2 pathway, and the interrelationship of the NOS and COX-2 pathways in retina and retinal cells, were investigated using a general inhibitor of NOS [ N G-nitro-l-arginine methyl ester (l-NAME)], specific inhibitors of iNOS [l- N 6-(1-iminoethyl)lysine (l-NIL)] and COX-2 (NS-398), and aspirin and aminoguanidine. In vitro studies used a transformed retinal Müller (glial) cell line (rMC-1) and primary bovine retinal endothelial cells (BREC) incubated in 5 and 25 mM glucose with and without these inhibitors, and in vivo studies utilized retinas from experimentally diabetic rats (2 mo) treated or without aminoguanidine or aspirin. Retinal rMC-1 cells cultured in high glucose increased production of NO and prostaglandin E 2(PGE 2) and expression of iNOS and COX-2. Inhibition of NO production with l-NAME or l-NIL inhibited all of these abnormalities, as did aminoguanidine and aspirin. In contrast, inhibition of COX-2 with NS-398 blocked PGE 2 production but had no effect on NO or iNOS. In BREC, elevated glucose increased NO and PGE 2 significantly, whereas expression of iNOS and COX-2 was unchanged. Viability of rMC-1 cells or BREC in 25 mM glucose was significantly less than at 5 mM glucose, and this cell death was inhibited by l-NAME or NS-398 in both cell types and also by l-NIL in rMC-1 cells. Retinal homogenates from diabetic animals produced significantly greater than normal amounts of NO and PGE 2 and of iNOS and COX-2. Oral aminoguanidine and aspirin significantly inhibited all of these increases. The in vitro results suggest that the hyperglycemia-induced increase in NO in retinal Müller cells and endothelial cells increases production of cytotoxic prostaglandins via COX-2. iNOS seems to account for the increased production of NO in Müller cells but not in endothelial cells. We postulate that NOS and COX-2 act together to contribute to retinal cell death in diabetes and to the development of diabetic retinopathy and that inhibition of retinopathy by aminoguanidine or aspirin is due at least in part to inhibition of this NO/COX-2 axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Self-citationRole of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Self-citationNonsteroidal Anti-inflammatory Drugs in Ophthalmology
Kim, S. J., Flach, A. J., & Jampol, L. M. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.07.005 · Cited by 383
Müller cells and diabetic retinopathy
Coughlin, B. A., Feenstra, D. J., & Mohr, S. (2017) · Vision Research · doi:10.1016/j.visres.2017.03.013 · Cited by 332
Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
Capitão, M., & Soares, R. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25575 · Cited by 312
Busik, J. V., Mohr, S., & Grant, M. B. (2008) · Diabetes · doi:10.2337/db07-1520 · Cited by 312
Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy
TODA, N., & NAKANISHITODA, M. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.01.004 · Cited by 311
Müller cells as players in retinal degeneration and edema
Reichenbach, A., Wurm, A., Pannicke, T., Iandiev, I., Wiedemann, P., & Bringmann, A. (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0516-y · Cited by 305
Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives
Madsen-Bouterse, S. A., & Kowluru, R. A. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9090-4 · Cited by 302
Retinal Ischemia and Reperfusion Causes Capillary Degeneration: Similarities to Diabetes
Zheng, L., Gong, B., Hatala, D. A., & Kern, T. S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0510 · Cited by 257
Self-citationEffects of p38 MAPK Inhibition on Early Stages of Diabetic Retinopathy and Sensory Nerve Function
Du, Y., Tang, J., Li, G., Berti-Mattera, L., Lee, C. A., Bartkowski, D., Gale, D., Monahan, J., Niesman, M. R., Alton, G., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3674 · Cited by 136
“Retinal homogenates were subjected to Western blot analysis, as reported by us previously.(18,19) Antibodies against iNOS (mAb; 1:500 dilution; Transduction Laboratories, Lexington, KY), nitrotyrosine (polyclonal; 1:1000 dilution; Upstate Biotechnology, Lake Placid, NY), COX-2 (polyclonal; 1:500 dilution; Cayman Chemi…”
MethodSelf-citationAljofan, M., & Ding, H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21986 · Cited by 58
Metadata
- Authors
- Du, Y., Sarthy, V. P., & Kern, T. S.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2004-10
- Volume
- 287
- Issue
- 4
- Pages
- R735-R741
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2033055869
- Cited by
- 169
- References
- 0
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.